Carnot CALYM

The Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field

The CALYM Carnot Institute fosters together 20 research teams specialized in lymphoma, first blood cancer. This academic consortium, without international equivalent, aims at accelerating innovation and its transfer in the lymphoma treatment and diagnosis through a unique R&D offer spanning from the identification of new biological targets to registration clinical trials.

Flip book presentation